U.S. Markets close in 5 hrs 37 mins

Biogen Stock Likely Won’t See a Boost From Buybacks, Analysts Say

Teresa Rivas

The biotech announced a $5 billion share-buyback plan, but Jefferies analyst Jared Holz says “stock buybacks [are] seldom value creating” but they could help bolster Biogen stock in the near term.